Skip to search boxSkip to navigationSkip to main content

Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes

  • Amy N. Luckenbaugh
    ,
  • Christopher J.D. Wallis
    ,
  • Li Ching Huang
    ,
  • Daniela Wittmann
    ,
  • ,
  • Zighuo Zhao
  • Vanderbilt University
    ,
  • University of Michigan, Ann Arbor
    ,
  • ,
  • ,
  • University of Texas at Austin
    ,
  • Emory University
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Results: A total of 2,742 men (median [quartiles] age 64 [59e70]) met inclusion criteria. Baseline depressive symptoms, as measured by the CES-D, were low (median 4, quartiles 1e8) without differences between groups. We found no effect of treatment modality on depressive symptoms (p[0.78), though older age, poorer health, being unmarried and baseline CES-D score were associated with declines in mental health. There was no clinically meaningful association between treatment modality and scores for either emotional well-being (p[0.81) or energy/fatigue (p[0.054). Conclusions: This prospective, population-based cohort study of men with localized prostate cancer showed no clinically important differences in mental health outcomes including depressive symptoms, emotional well-being, and energy/fatigue according to the treatment received (surgery, radiotherapy, or surveillance). However, we identified a number of characteristics associated with worse mental health outcomes including: older age, poorer health, being unmarried, and baseline CES-D score which may allow for early identification of patients most at risk of these outcomes following treatment.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1029-1037 (9 pages)

Journal (Volume, Issue Number)

Journal of Urology (Volume 207, Issue 5)

Publication milestones

  • Published - 05/01/2022

Publication status

Published - 05/01/2022

ISSN

0022-5347

Publication IDs

  • Scopus: 85128250964
  • PubMed: 34978488

Publication metrics

Metrics

Fractional count
1
Fractional count
0.05
Fractional count
21
Fractional count
0.95
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Mentions
4
Captures
30
Citation count
23
Social media
5
Usage
19

Funding Details

Support: This work was supported by the Agency for Healthcare Research and Quality (1R01HS019356, 1R01HS022640, R01CA230352); the Patient-Centered Outcomes Research Institute (CE-12-11-4667); and the National Cancer Institute (NIH/NCI grant 5T32CA106183). Data management was facilitated by Vanderbilt University's Research Electronic Data Capture (REDCap) system, which is supported by the Vanderbilt Institute for Clinical and Translational Research grant (UL1TR000011 from NCATS/NIH). The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. Conflict of Interest: The authors have no disclosures relevant to this work. This article was written on behalf of all CEASAR investigators. Support: This work was supported by the Agency for Healthcare Research and Quality (1R01HS019356, 1R01HS022640, R01CA230352); the Patient-Centered Outcomes Research Institute (CE-12-11-4667); and the National Cancer Institute (NIH/NCI grant 5T32CA106183). Data management was facilitated by Vanderbilt University’s Research Electronic Data Capture (REDCap) system, which is supported by the Vanderbilt Institute for Clinical and Translational Research grant (UL1TR000011 from NCATS/NIH). The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
FundersFunding numbers
NCATS
-
VU
-
VICTR
UL1TR000011
PCORI
CE-12-11-4667
NCI
R01CA230352, T32CA106183
AHRQ
1R01HS022640, 1R01HS019356, R01CA230352
-
R01HS022640